{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:10:57Z","timestamp":1793459457329,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"am","delay-in-days":295,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["223fa627003h0001"],"award-info":[{"award-number":["223fa627003h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["J22JK00035"],"award-info":[{"award-number":["J22JK00035"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["J22JK00041"],"award-info":[{"award-number":["J22JK00041"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["J22JK00135"],"award-info":[{"award-number":["J22JK00135"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H05280"],"award-info":[{"award-number":["18H05280"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18KK0432"],"award-info":[{"award-number":["18KK0432"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03856"],"award-info":[{"award-number":["20H03856"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08514"],"award-info":[{"award-number":["20K08514"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["G20K20495"],"award-info":[{"award-number":["G20K20495"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.molmed.2022.10.009","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T08:57:27Z","timestamp":1669193847000},"page":"124-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Nasal vaccines: solutions for respiratory infectious diseases"],"prefix":"10.1016","volume":"29","author":[{"given":"Rika","family":"Nakahashi-Ouchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Fujihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kurashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-4658","authenticated-orcid":false,"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2022.10.009_bb0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2183\/pjab.91.423","article-title":"The mucosal immune system: from dentistry to vaccine development","volume":"91","author":"Kiyono","year":"2015","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.molmed.2022.10.009_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coviro.2012.03.009","article-title":"The mucosal immune system of the respiratory tract","volume":"2","author":"Sato","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fimmu.2013.00185","article-title":"Multi-faceted functions of secretory IgA at mucosal surfaces","volume":"4","author":"Corth\u00e9sy","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.10.009_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2022.10.009_bb0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0194599820982633","article-title":"COVID-19 vaccines may not prevent nasal SARS-CoV-2 infection and asymptomatic transmission","volume":"164","author":"Bleier","year":"2021","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.molmed.2022.10.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120686","article-title":"Nasal vaccination against SARS-CoV-2: synergistic or alternative to intramuscular vaccines?","volume":"603","author":"Tiboni","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molmed.2022.10.009_bb0040","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1586\/erv.09.61","article-title":"Mucosal vaccines: novel advances in technology and delivery","volume":"8","author":"Yuki","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.molmed.2022.10.009_bb0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/intimm\/dxab056","article-title":"Mucosal vaccines: wisdom from now and then","volume":"33","author":"Kiyono","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0050","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2022.10.009_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2045853","article-title":"COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges","volume":"18","author":"Dhama","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.molmed.2022.10.009_bb0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2174\/156720112803529828","article-title":"Anatomical and histological factors affecting intranasal drug and vaccine delivery","volume":"9","author":"Gizurarson","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.molmed.2022.10.009_bb0065","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.4843","article-title":"Motile and non-motile cilia in human pathology: from function to phenotypes","volume":"241","author":"Mitchison","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1378\/chest.08-0412","article-title":"Mucins, mucus, and sputum","volume":"135","author":"Voynow","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.molmed.2022.10.009_bb0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1248\/bpb.b14-00398","article-title":"The effect of cilia and the mucociliary clearance on successful drug delivery","volume":"38","author":"Gizurarson","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.molmed.2022.10.009_bb0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/02652048.2022.2051626","article-title":"The nanotechnological approach for nasal delivery of peptide drugs: a comprehensive review","volume":"39","author":"Zuglianello","year":"2022","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.molmed.2022.10.009_bb0085","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.otc.2005.07.006","article-title":"Olfactory and sensory attributes of the nose","volume":"38","author":"Wrobel","year":"2005","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"10.1016\/j.molmed.2022.10.009_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"G\u00e4nger","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.molmed.2022.10.009_bb0095","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ar.23844","article-title":"The nasal cavity of the rat and mouse \u2013 source of mesenchymal stem cells for treatment of peripheral nerve injury","volume":"301","author":"Alvites","year":"2018","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.molmed.2022.10.009_bb0100","series-title":"Micro and Nanotechnology in Vaccine Development","first-page":"279","article-title":"Nasal vaccine delivery","author":"Ramvikas","year":"2017"},{"key":"10.1016\/j.molmed.2022.10.009_bb0105","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.vaccine.2015.07.022","article-title":"Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT) \u2013 structure, function and species differences","volume":"33","author":"Pabst","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2022.10.009_bb0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0167-5699(98)01307-3","article-title":"Immunology of the tonsils","volume":"19","author":"Perry","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.molmed.2022.10.009_bb0115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus PEYER'S-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1574-695X.2007.00359.x","article-title":"M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis","volume":"52","author":"Corr","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.182.1.5","article-title":"The surprising discovery that TGF\u03b2 specifically induces the IgA class switch","volume":"182","author":"Stavnezer","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fimmu.2014.00065","article-title":"Cytokine-mediated regulation of plasma cell generation: IL-21 takes center stage","volume":"5","author":"Moens","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0135","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.4049\/jimmunol.0903794","article-title":"The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens","volume":"186","author":"Kim","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/14760584.2017.1395702","article-title":"Development of a nanogel-based nasal vaccine as a novel antigen delivery system","volume":"16","author":"Nakahashi-Ouchida","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.molmed.2022.10.009_bb0145","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.3390\/ijms22052284","article-title":"Role of polymeric immunoglobulin receptor in IgA and IgM transcytosis","volume":"22","author":"Wei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2022.10.009_bb0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2013.00222","article-title":"Secretory IgA: designed for anti-microbial defense","volume":"4","author":"Brandtzaeg","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0155","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.10.009_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.ai.2018.02.002","article-title":"Chemokines: critical regulators of memory T cell development, maintenance, and function","volume":"138","author":"Rahimi","year":"2018","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0165","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.3389\/fimmu.2022.953088","article-title":"Resident memory B cells in barrier tissues","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0170","doi-asserted-by":"crossref","first-page":"40733","DOI":"10.1371\/journal.pone.0040733","article-title":"Pulmonary infection with influenza A virus induces site-specific germinal center and T follicular helper cell responses","volume":"7","author":"Boyden","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2022.10.009_bb0175","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/icb.2014.59","article-title":"Human memory B cells isolated from blood and tonsils are functionally distinctive","volume":"92","author":"P\u00e9rez","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0180","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2013.02.023","article-title":"B-lymphocyte lineage cells and the respiratory system","volume":"131","author":"Kato","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0185","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni.2053","article-title":"The development of inducible bronchus-associated lymphoid tissue depends on IL-17","volume":"12","author":"Rangel-Moreno","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41385-021-00461-z","article-title":"Tissue resident memory T cells in the respiratory tract","volume":"15","author":"Zheng","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb6808","article-title":"T resident helper cells promote humoral responses in the lung","volume":"6","author":"Swarnalekha","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb6852","article-title":"Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses","volume":"6","author":"Son","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines","volume":"58","author":"Tamura","year":"2005","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.molmed.2022.10.009_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj5129","article-title":"Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA","volume":"6","author":"Oh","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0215","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0264-410X(99)00334-5","article-title":"Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses","volume":"18","author":"Treanor","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2022.10.009_bb0220","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/MLG.0b013e3180383651","article-title":"Upper airway mucin gene expression: a review","volume":"117","author":"Ali","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.molmed.2022.10.009_bb0225","first-page":"634","article-title":"Nasal absorption of drugs \u2013 barriers and solutions","volume":"2","author":"Dehghan","year":"2009","journal-title":"Res. J. Pharm. Tech."},{"key":"10.1016\/j.molmed.2022.10.009_bb0230","first-page":"22","article-title":"Nasal cavity, a promising transmucosal platform for drug delivery and research approaches from nasal to brain targetting","volume":"2","author":"Singh","year":"2012","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.molmed.2022.10.009_bb0235","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"Robert-Guroff","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0240","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1038\/s41467-020-20228-7","article-title":"A single dose of recombinant VSV-\u2206G-spike vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Yahalom-Ronen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.10.009_bb0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fmolb.2021.635337","article-title":"Developmental landscape of potential vaccine candidates based on viral vector for prophylaxis of COVID-19","volume":"8","author":"Bezbaruah","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.molmed.2022.10.009_bb0250","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines2030624","article-title":"Developments in viral vector-based vaccines","volume":"2","author":"Ura","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.molmed.2022.10.009_bb0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.imlet.2018.03.006","article-title":"Live bacterial vaccine vector and delivery strategies of heterologous antigen: a review","volume":"197","author":"Ding","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molmed.2022.10.009_bb0260","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00061-18","article-title":"Lactobacillus mucosal vaccine vectors: immune responses against bacterial and viral antigens","volume":"3","author":"LeCureux","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.molmed.2022.10.009_bb0265","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijbiomac.2021.08.232","article-title":"Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2","volume":"190","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100432","article-title":"Adenovirus vector-based vaccine for infectious diseases","volume":"42","author":"Sakurai","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.molmed.2022.10.009_bb0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.molmed.2022.10.009_bb0280","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/polym13071027","article-title":"Recent advancements in polymer\/liposome assembly for drug delivery: from surface modifications to hybrid vesicles","volume":"13","author":"De Leo","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.molmed.2022.10.009_bb0285","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.3389\/fphar.2021.757761","article-title":"Nanocarriers-assisted needle-free vaccine delivery through oral and intranasal transmucosal routes: a novel therapeutic conduit","volume":"12","author":"Mangla","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0290","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.molmed.2022.10.009_bb0295","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/ejlt.201400219","article-title":"The use of natural and synthetic phospholipids as pharmaceutical excipients","volume":"116","author":"van Hoogevest","year":"2014","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0300","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1039\/C6NR03256G","article-title":"Recent advances in chitosan-based nanoparticulate pulmonary drug delivery","volume":"8","author":"Islam","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.molmed.2022.10.009_bb0305","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/mp200572t","article-title":"Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: Microscopic, ultrastructural, and computed-tomographic observations","volume":"9","author":"Sonaje","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.molmed.2022.10.009_bb0310","first-page":"229","article-title":"Chemical modification of chitosan for efficient vaccine delivery","volume":"23","author":"Xing","year":"2018","journal-title":"Mol. A J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.molmed.2022.10.009_bb0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11705-018-1729-4","article-title":"Recent research and development of PLGA\/PLA microspheres\/nanoparticles: a review in scientific and industrial aspects","volume":"13","author":"Qi","year":"2019","journal-title":"Front. Chem. Sci. Eng."},{"key":"10.1016\/j.molmed.2022.10.009_bb0320","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/02648725.2013.801226","article-title":"Nanogel-based antigen-delivery system for nasal vaccines","volume":"29","author":"Yuki","year":"2013","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.molmed.2022.10.009_bb0325","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1080\/21645515.2018.1461298","article-title":"Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases","volume":"14","author":"Nakahashi-Ouchida","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.molmed.2022.10.009_bb0330","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/bc700422s","article-title":"Self-assembled cationic nanogels for intracellular protein delivery","volume":"19","author":"Ayame","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.molmed.2022.10.009_bb0335","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0026-2862(91)90084-O","article-title":"Endothelial surface charge of intestinal mucosal capillaries and its modulation by dextran","volume":"42","author":"Baldwin","year":"1991","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.molmed.2022.10.009_bb0340","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nmat2784","article-title":"Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines","volume":"9","author":"Nochi","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.molmed.2022.10.009_bb0345","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/IAI.00240-13","article-title":"Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae","volume":"81","author":"Gyu Kong","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molmed.2022.10.009_bb0350","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/mi.2015.5","article-title":"Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques","volume":"8","author":"Fukuyama","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0355","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2021.04.069","article-title":"A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci","volume":"39","author":"Nakahashi-Ouchida","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2022.10.009_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.819859","article-title":"Induction of mucosal IgA-mediated protective immunity against nontypeable Haemophilus influenzae infection by a cationic nanogel-based P6 nasal vaccine","volume":"13","author":"Nakahashi-ouchida","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0365","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0370","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.celrep.2019.08.004","article-title":"\u03b2-Glucan-induced trained immunity protects against Leishmania braziliensis infection: a crucial role for IL-32","volume":"28","author":"dos Santos","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2022.10.009_bb0375","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2022.10.009_bb0380","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O'Neill","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0385","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157393","article-title":"Bacillus Calmette\u2013Gu\u00e9rin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice","volume":"7","author":"Zhang","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2022.10.009_bb0390","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2022.10.009_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009928","article-title":"Induction of trained immunity by influenza vaccination - impact on COVID-19","volume":"17","author":"Debisarun","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2022.10.009_bb0400","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cell.2018.11.007","article-title":"Trained immunity and local innate immune memory in the lung","volume":"175","author":"Netea","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2022.10.009_bb0405","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8563","article-title":"Comparison of replicating and nonreplicating vaccines against SARS-CoV-2","volume":"8","author":"Mudrick","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2022.10.009_bb0410","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci. Bull."},{"key":"10.1016\/j.molmed.2022.10.009_bb0415","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/vaccines8040771","article-title":"A Newcastle disease virus (NDV) expressing a membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine","volume":"8","author":"Sun","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.molmed.2022.10.009_bb0420","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2022.10.009_bb0425","article-title":"Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose vaccine and as a booster against SARS-CoV-2 Variants","author":"Beavis","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.molmed.2022.10.009_bb0430","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi5246","article-title":"Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine","volume":"7","author":"An","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.molmed.2022.10.009_bb0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2022.10.009_bb0440","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"Van Doremalen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2022.10.009_bb0445","article-title":"Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy","volume":"118","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.10.009_bb0450","doi-asserted-by":"crossref","first-page":"13916","DOI":"10.1038\/ncomms13916","article-title":"A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation","volume":"7","author":"Stobart","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.10.009_bb0455","article-title":"The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigen","author":"Limonta-Fern\u00e1ndez","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.molmed.2022.10.009_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.836745","article-title":"Safety and efficacy of combined intramuscular\/Intranasal RAZI-COV PARS vaccine candidate against SARS-CoV-2: a preclinical study in several animal models","volume":"13","author":"Banihashemi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0465","article-title":"Next-generation intranasal COVID-19 vaccine: a polymersome-based protein subunit formulation that provides robust protection against multiple variants of concern and early reduction in viral load of the upper airway in the golden Syrian hamster model","author":"Lam","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.molmed.2022.10.009_bb0470","doi-asserted-by":"crossref","first-page":"15754","DOI":"10.1021\/acsnano.1c01243","article-title":"Polymersomes as stable nanocarriers for a highly immunogenic and durable SARS-CoV-2 spike protein subunit vaccine","volume":"15","author":"Lam","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.molmed.2022.10.009_bb0475","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.vaccine.2021.03.006","article-title":"Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse","volume":"39","author":"Du","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2022.10.009_bb0480","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.chom.2020.12.010","article-title":"Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models","volume":"29","author":"Ku","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2022.10.009_bb0485","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148494","article-title":"Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques","volume":"6","author":"Sui","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2022.10.009_bb0490","first-page":"658","article-title":"Development and delivery systems of mRNA vaccines","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0495","article-title":"Recent advances in the molecular design and delivery technology of mRNA for vaccination against infectious diseases","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2016.02.043","article-title":"Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways","volume":"228","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molmed.2022.10.009_bb0505","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1158\/0008-5472.CAN-11-2957","article-title":"Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy","volume":"72","author":"Van Lint","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2022.10.009_bb0510","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00262-014-1558-3","article-title":"Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula","volume":"63","author":"Van Lint","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.molmed.2022.10.009_bb0515","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"(2021) SARS-CoV-2 variants, spike mutations and immune escape","volume":"197","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0520","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2022.10.009_bb0525","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0530","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines \u2013 fortifying the frontiers","volume":"22","author":"Lavelle","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0535","author":"US FDA"},{"key":"10.1016\/j.molmed.2022.10.009_bb0540","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist\u00ae; FluenzTM): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.molmed.2022.10.009_bb0545","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm1726","article-title":"Engineering attenuated virus vaccines by controlling replication fidelity","volume":"14","author":"Vignuzzi","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2022.10.009_bb0550","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/vim.2017.0026","article-title":"Modes of action for mucosal vaccine adjuvants","volume":"30","author":"Aoshi","year":"2017","journal-title":"Viral Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0555","author":"US Centers for Disease Control and Prevention"},{"key":"10.1016\/j.molmed.2022.10.009_bb0560","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1016\/j.vaccine.2013.05.068","article-title":"Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40\u201370 years of age","volume":"31","author":"Heyward","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2022.10.009_bb0565","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","article-title":"Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.molmed.2022.10.009_bb0570","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2022.10.009_bb0575","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.molmed.2022.10.009_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2022.10.009_bb0585","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.5665\/sleep.5752","article-title":"Risk of narcolepsy after AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine in adults: a case-coverage study in England","volume":"39","author":"Stowe","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.molmed.2022.10.009_bb0590","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/awt187","article-title":"Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France","volume":"136","author":"Dauvilliers","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2022.10.009_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139368","article-title":"Nasal administration of cholera toxin as a mucosal adjuvant damages the olfactory system in mice","volume":"10","author":"Fukuyama","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2022.10.009_bb0600","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.molmed.2022.10.009_bb0605","first-page":"101","article-title":"Olfaction: from odorant molecules to the olfactory cortex","volume":"19","author":"Menini","year":"2004","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.molmed.2022.10.009_bb0610","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","volume":"165","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0615","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00441-014-2093-4","article-title":"Autoradiography techniques and quantification of drug distribution","volume":"360","author":"Solon","year":"2015","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.molmed.2022.10.009_bb0620","author":"European Medicines Agency"},{"key":"10.1016\/j.molmed.2022.10.009_bb0625","author":"European Medicines Agency"},{"key":"10.1016\/j.molmed.2022.10.009_bb0630","author":"European Medicines Agency"},{"key":"10.1016\/j.molmed.2022.10.009_bb0635","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1021\/bc1004697","article-title":"Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery","volume":"22","author":"Asai","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.molmed.2022.10.009_bb0640","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.4049\/jimmunol.1001789","article-title":"In vivo molecular imaging analysis of a nasal vaccine that induces protective immunity against botulism in nonhuman primates","volume":"185","author":"Yuki","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.10.009_bb0645","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuron.2020.06.032","article-title":"COVID-19 and the chemical senses: supporting players take center stage","volume":"107","author":"Cooper","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2022.10.009_bb0650","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8396","article-title":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters","volume":"13","author":"de Melo","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2022.10.009_bb0655","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2022.10.009_bb0660","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2022.10.009_bb0665","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/d41586-022-02851-0","article-title":"China and India approve nasal COVID vaccines \u2013 are they a game changer?","volume":"609","author":"Waltz","year":"2022","journal-title":"Nature"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142200274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142200274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:26:29Z","timestamp":1761463589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149142200274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S147149142200274X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2022.10.009","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasal vaccines: solutions for respiratory infectious diseases","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2022.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}